Cargando…
Nano Drug Delivery System for Tumor Immunotherapy: Next-Generation Therapeutics
Tumor immunotherapy is an artificial stimulation of the immune system to enhance anti-cancer response. It has become a powerful clinical strategy for treating cancer. The number of immunotherapy drug approvals has been increasing in recent years, and many treatments are in clinical and preclinical s...
Autores principales: | Zhou, Lili, Zou, Manshu, Xu, Yilin, Lin, Peng, Lei, Chang, Xia, Xinhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160744/ https://www.ncbi.nlm.nih.gov/pubmed/35664731 http://dx.doi.org/10.3389/fonc.2022.864301 |
Ejemplares similares
-
Melanoma Immunotherapy: Next-Generation Biomarkers
por: Hogan, Sabrina A., et al.
Publicado: (2018) -
Cancer Immunotherapy and Next-Generation Clinical Immune Assessment
por: Ma, Chao, et al.
Publicado: (2014) -
Next-Generation Cancer Immunotherapy Targeting Glypican-3
por: Shimizu, Yasuhiro, et al.
Publicado: (2019) -
Engineered multifunctional nanocarriers for controlled drug delivery in tumor immunotherapy
por: Katopodi, Theodora, et al.
Publicado: (2022) -
Next Generation CAR T Cells for the Immunotherapy of High-Grade Glioma
por: Petersen, Christopher T., et al.
Publicado: (2019)